Company news

Pathkey.AI Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Treasury Update

June 25, 2025

OPL & Innovatrix to Launch Clinical Trial Insurance Product

June 18, 2025

OPL Deepens Global AI Collaborations - Cardialysis & Evestia

June 11, 2025

OPL Completes Strategic Review

June 9, 2025

Completion of $1.5m Oversubscribed Placement

May 1, 2025

OPL - Appendix 4D & Half Year Results

February 27, 2025

Opyl Announces Partnership with Avion

February 7, 2025

OPL Signs Landmark JV with X Firm Ltd

January 6, 2025

OPL Signs Partnership Agreement with NeuOrphan

December 10, 2024

OPL Partners L39 Capital to Launch AI-Powered Biotech Fund

December 9, 2024

OPL Signs Service Agreement with Southern CDC

November 20, 2024

Updated Quarterly Activities & Cashflow Report

October 29, 2024

Opyl Signs New Service Agreement with Commercial Eyes

October 15, 2024

Opyl Signs New Service Agreement with Biointelect

September 24, 2024

Strategic Partnership with Phenix Health Compendium Platform

September 22, 2024

Opyl Enters Strategic Partnership with Alithia Life Sciences

September 16, 2024

Opyl - Full Year Results

August 29, 2024

Opyl - Appendix 4E

August 29, 2024

Opyl Secures $700K loans to advance TrialKey & Drive Growth

August 21, 2024

Opyl - Business Update & Appendix 4C

July 30, 2024

OPL signs MOU for EMEA & US Expansion

July 23, 2024

Opyl Partners with L39 Capital to Launch AI Biotech Fund

July 8, 2024

Opyl Announces First Trial Gen Revenue & Customer

June 5, 2024

Opyl signs binding agreement for sale of Opin business

April 22, 2024

Reinstatement to Quotation

March 22, 2024

Opyl receives non-binding offer for its Opin business

March 22, 2024

Suspension from Quotation

March 21, 2024

Request for Trading Halt

March 20, 2024

Pause in Trading

March 20, 2024

Successful Placement of Rights Issue Shortfall

February 7, 2024

Opin Signs New $282K Patient Recruitment Contract

February 4, 2024

Rights Offer Booklet

December 21, 2023

Opyl Opens Rights Offer

December 21, 2023

Opyl completes Placement and launches Entitlement Offer

December 12, 2023

Opyl Appoints Chief Executive Officer

November 23, 2023

Opyl Receives $530K R&D Tax Refund

September 21, 2023

TrialKey MVP Launched / Strategy Update Webcast

August 24, 2023

Opyl Announces Leadership Changes & Strategic Realignment

July 5, 2023

Opyl completes Placement and secures short term loan

July 3, 2023

Successful Placement of Shortfall Shares from Rights Issue

April 4, 2023

Appendix 4D & Half Year Results

February 26, 2023

Opyl enters into MSA and new clinical trial recruitment

January 17, 2023

Opyl completes Placement and launches Rights Issue

December 23, 2022

Suspension from Official Quotation

December 23, 2022

Opyl - world-first mapping & linking clinical trial data

October 19, 2022

Opyl Receives $570K R&D Tax Refund

October 18, 2022

Opyl - Appendix 4E & Annual Report

August 30, 2022

Opyl - FY22 Results Announcement

August 30, 2022

Opyl 2021 AGM Presentation 18 November 2021

November 18, 2021

Opyl - August Full Year Investor Update

August 30, 2021

← Newer news releases · Older news releases →

Decks

The 5 newest of 6 decks. Every deck is listed under its year.